Heart Health Innovator Cleerly Closes Series C Funding Round with $192 Million
High-profile investors led by T. Rowe Price and Fidelity back a new standard of care for cardiovascular disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192 million. This new funding brings the total raised by the fast-growing … [Read more…]